Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A2 | O15244 | 1/20 | 0.56 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.41 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.41 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31345052 | 0.88 | — | — | |
| SCHEMBL25237741 | 0.88 | — | — | |
| SCHEMBL14315587 | 0.87 | SLC22A2 (0.44) | SLC22A2SLC47A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL14315572 | 0.87 | SLC22A2 (0.44) | SLC22A2SLC47A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL7737331 | 0.84 | GRIN2D (0.48) | SLC22A2SLC47A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL1035318 | 0.82 | SLC22A2 (0.40) | SLC22A2SLC47A1MAPTSMN1; SMN2NPC1 | |
| Acrylic Acid SCHEMBL11261108 | 0.82 | NPC1 (0.43) | SLC22A2SLC47A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL2961008 | 0.79 | SMN1; SMN2 (0.53) | SLC22A2SLC47A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL20042206 | 0.79 | SMN1; SMN2 (0.53) | SLC22A2SLC47A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL19758138 | 0.79 | SMN1; SMN2 (0.53) | SLC22A2SLC47A1MAPTSMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751879-A | Adamantane modified silane coupling agent, single-component dealcoholized silicone rubber and preparation method thereof | 广州白云科技股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-109971438-B | Modified starch coated anti-sloughing agent for drilling fluid and preparation method thereof | 中国石油化工股份有限公司 | 2021-05-18 | — | — | CN | claimed |
| US-8481016-B2 | Method for inhibition of potential-dependent cation channel | KAO CORPORATION (JP) | 2013-07-09 | — | — | US | claimed |
| US-8431656-B2 | Curable cyclic phosphazene compound and method of preparing the same | SAMSUNG ELECTRO-MECHANICS CO. LTD. (KR) | 2013-04-30 | — | — | US | claimed |
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | KAO CORPORATION (JP) | 2013-02-21 | — | — | US | claimed |
| US-20110028584-A1 | CURABLE CYCLIC PHOSPHAZENE COMPOUND AND METHOD OF PREPARING THE SAME | SAMSUNG ELECTRO-MECHANICS CO., LTD. (KR) | 2011-02-03 | — | — | US | claimed |
| US-7235342-B2 | Negative photoresist composition including non-crosslinking chemistry | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2007-06-26 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-20050164507-A1 | Negative photoresist composition including non-crosslinking chemistry | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2005-07-28 | — | — | US | claimed |
| US-6797745-B1 | Hot melt inks containing styrene or terpene polymers | XEROX CORPORATION | 2004-09-28 | — | — | US | claimed |
| US-5922117-A | Ink compositions containing alcohols | XEROX CORPORATION (US) | 1999-07-13 | — | — | US | claimed |
| CN-122070936-A | Nanometer material based on supermolecule polypeptide-drug coupling prodrug, and preparation method and application thereof | 中国医学科学院生物医学工程研究所 | 2026-05-22 | — | — | CN | disclosed |
| CN-121450214-A | High-performance formula of pencil wax sealing primer and preparation method thereof | 浙江安益新材料有限公司 | 2026-02-03 | — | — | CN | disclosed |
| US-12404300-B2 | Mitochondria-targeting peptides | STEALTH BIOTHERAPEUTICS INC. (US) | 2025-09-02 | — | — | US | disclosed |
| US-20250215318-A1 | ETCHING COMPOSITION, ETCHING METHOD USING SAME, AND METHOD FOR MANUFACTURING ELECTRONIC COMPONENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-0243116-A2 | Optical sensor | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-10-28 | — | — | EP | disclosed |
| EP-0174956-A1 | SOFT -g(b)-ADRENERGIC BLOCKING AGENTS. | BODOR NICHOLAS S | 1986-03-26 | — | — | EP | disclosed |
| WO-1985004168-A1 | SOFT beta-ADRENERGIC BLOCKING AGENTS | BODOR NICHOLAS S | 1985-09-26 | — | — | WO | disclosed |
| EP-0053621-A1 | UNSATURATED ESTERS OF ADAMANTANE CONTAINING DIOLS AND THERMO-RESISTANT CROSS-LINKED POLYMERS THEREFROM. | BATTELLE MEMORIAL INSTITUTE (CH) | 1982-06-16 | — | — | EP | disclosed |
| WO-1981003657-A1 | UNSATURATED ESTERS OF ADAMANTANE CONTAINING DIOLS AND THERMO-RESISTANT CROSS-LINKED POLYMERS THEREFROM | BATTELLE MEMORIAL INSTITUTE (CH) | 1981-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | TRPM7, TRPM8, OR10J3 | SLC22A2 1777/4885SLC47A1 441/4885MAPT 4039/4885 |
| US-20110028584-A1 | CURABLE CYCLIC PHOSPHAZENE COMPOUND AND METHOD OF PREPARING THE SAME | PHOSPHO1, PPIP5K2, PLK1 | SLC22A2 3558/4885SLC47A1 4699/4885MAPT 1944/4885 |
| US-12404300-B2 | Mitochondria-targeting peptides | SSBP1, HSPE1, IMMT | SLC22A2 970/4885SLC47A1 1009/4885MAPT 2171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.